three independent sources of data -- placebo-controlled trials , pharmaceutical company reports , and the san francisco men 's health study -- were used to demonstrate that the amounts of zidovudine ( azt ) given prophylactically to those at highest risk of aids since march 1987 have been sufficient to account for most of the observed aids deficits .
C0043474
azt
C0001175
aids